Related Experiment Video
Updated: May 6, 2026
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
Safety and accuracy of core biopsy in retroperitoneal sarcomas
Sang Yun Hwang1,2, Sanjay Warrier1,2, Stephen Thompson1,3,4
1Prince of Wales Hospital Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Aim:
Retroperitoneal sarcomas (RPSs) are large, rare tumors. The role of core biopsy for retroperitoneal masses identified by preoperative imaging is unclear and we report the safety and accuracy of core biopsies at a specialized sarcoma unit in Sydney, Australia.
Methods:
A retrospective analysis of a prospectively collected database was performed to identify the safety and accuracy of core biopsies in patients who were confirmed to have RPS.
Results:
Twenty-two patients underwent biopsies with no recorded morbidity or tumor seeding. RPS was correctly identified in 82%. Median follow-up was 19 months.
Conclusion:
We demonstrate that core biopsy is safe and can identify RPSs.
More Related Videos
06:42Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
Published on: September 2, 2025
07:34Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
